Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Jernberg

Showing results (161-170 of 345) with videos related to

Pageof 35
Sort By:
European Journal of Preventive Cardiology|June 6, 2024
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individualsAli Yari, Peter Ueda, Pia Lundman, et al.
European Heart Journal|July 21, 2016
Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registryAnders Sahlén, Christoph Varenhorst, Bo Lagerqvist, et al.
Journal of the American College of Cardiology|April 16, 2025
Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART RegistryMargret Leosdottir, Jessica Schubert, Julia Brandts, et al.
Scientific Reports|July 27, 2023
Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged populationSofia Cederström, Pia Lundman, Joakim Alfredsson, et al.
Journal of the American Heart Association|February 27, 2019
Development and Validation of a Novel Risk Score for In-Hospital Major Bleeding in Acute Myocardial Infarction:-The SWEDEHEART ScoreMoa Simonsson, Henric Winell, Henrik Olsson, et al.
BMJ Open|April 6, 2019
Impact of ischaemic heart disease severity and age on risk of cardiovascular outcome in diabetes patients in Sweden: a nationwide observational studyTomas Jernberg, Daniel Lindholm, Lars Pål Hasvold, et al.
Alimentary Pharmacology & Therapeutics|March 1, 2024
Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort StudyCarl Eriksson, Jiangwei Sun, Matti Bryder, et al.
European Journal of Preventive Cardiology|April 11, 2025
Attention-deficit/hyperactivity disorder and cardiometabolic risk profile in patients with acute myocardial infarction: data from the SWEDEHEART registryHonghui Yao, Isabell Brikell, Henrik Larsson, et al.
JAMA|March 6, 2014
Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillationJuan Jesús Carrero, Marie Evans, Karolina Szummer, et al.
Heart (British Cardiac Society)|August 30, 2024
Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome: a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty RegistrySacharias von Koch, Sasha Koul, Per Grimfjärd, et al.
Pageof 35

Showing results (161-170 of 345) with videos related to

Sort By:
Pageof 35
European Journal of Preventive Cardiology|June 6, 2024
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individualsAli Yari, Peter Ueda, Pia Lundman, et al.
European Heart Journal|July 21, 2016
Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registryAnders Sahlén, Christoph Varenhorst, Bo Lagerqvist, et al.
Journal of the American College of Cardiology|April 16, 2025
Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART RegistryMargret Leosdottir, Jessica Schubert, Julia Brandts, et al.
Scientific Reports|July 27, 2023
Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged populationSofia Cederström, Pia Lundman, Joakim Alfredsson, et al.
Journal of the American Heart Association|February 27, 2019
Development and Validation of a Novel Risk Score for In-Hospital Major Bleeding in Acute Myocardial Infarction:-The SWEDEHEART ScoreMoa Simonsson, Henric Winell, Henrik Olsson, et al.
BMJ Open|April 6, 2019
Impact of ischaemic heart disease severity and age on risk of cardiovascular outcome in diabetes patients in Sweden: a nationwide observational studyTomas Jernberg, Daniel Lindholm, Lars Pål Hasvold, et al.
Alimentary Pharmacology & Therapeutics|March 1, 2024
Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort StudyCarl Eriksson, Jiangwei Sun, Matti Bryder, et al.
European Journal of Preventive Cardiology|April 11, 2025
Attention-deficit/hyperactivity disorder and cardiometabolic risk profile in patients with acute myocardial infarction: data from the SWEDEHEART registryHonghui Yao, Isabell Brikell, Henrik Larsson, et al.
JAMA|March 6, 2014
Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillationJuan Jesús Carrero, Marie Evans, Karolina Szummer, et al.
Heart (British Cardiac Society)|August 30, 2024
Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome: a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty RegistrySacharias von Koch, Sasha Koul, Per Grimfjärd, et al.
Pageof 35